Universite Paris-Sud 11;Ecole Nationale Superieure de Chimie de Montpellier;Universite Montpellier 2 Scie;Universite Paris-Nord 13;Centre National de la Recherche Scientifique;Universite Montpellier 1
The invention relates to the use of compounds of formula (1) as defined in the description, for reducing or preventing the onset of metastases in a patient suffering from cancer. The invention also relates to pharmaceutical compositions for using in human or veterinary medicine, comprising at least one compound of formula (1).